What you need to know about the Drug Supply Chain Security Act
As the pharmaceutical industry barrels towards November 27, 2023, more and more pharma companies are asking for help understanding the requirements to comply with the Drug Supply Chain Security Act (DSCSA).
Archbow team member, Rob Besse, wrote a concise overview of DSCSA for Pharmaceutical Executive to help pharma and biotech professionals quickly understand the most important elements of these new Track-and-Trace regulations. The article includes a history of the DSCSA, an important timeline everyone should understand (see below), an update on how the industry is adjusting so far, and information on why it may finally be time to embrace blockchain technology.
It is vital to begin asking questions about your company’s DSCSA readiness and compliance, as well as that of your strategic partners, if you have not already. Consulting partners, like Archbow Consulting, can provide guidance and lend expertise while identifying the best resources available to reach full compliance. Contact us today to get started.
Special thanks to Matt Sample and Heather Zenk at AmerisourceBergen for lending their expertise to this article.
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn, Twitter or subscribing to this blog which you can do below.